[HTML][HTML] Metabolic syndrome, endocrine disruptors and prostate cancer associations: biochemical and pathophysiological evidences
V Quagliariello, S Rossetti, C Cavaliere, R Di Palo… - Oncotarget, 2017 - ncbi.nlm.nih.gov
This review summarizes the main pathophysiological basis of the relationship between
metabolic syndrome, endocrine disruptor exposure and prostate cancer that is the most …
metabolic syndrome, endocrine disruptor exposure and prostate cancer that is the most …
MicroRNA‐181a promotes docetaxel resistance in prostate cancer cells
CM Armstrong, C Liu, W Lou, AP Lombard… - The …, 2017 - Wiley Online Library
BACKGROUND Docetaxel is one of the primary drugs used for treating castration resistant
prostate cancer (CRPC). Unfortunately, over time patients invariably develop resistance to …
prostate cancer (CRPC). Unfortunately, over time patients invariably develop resistance to …
Anticancer potential of novel curcumin analogs towards castrate-resistant prostate cancer
S Chen, M Nimick, AG Cridge… - International …, 2017 - spandidos-publications.com
Prostate cancer is initially sensitive to hormone therapy; however, over time the majority of
patients progress to a hormone-insensitive form classified as castration-resistant prostate …
patients progress to a hormone-insensitive form classified as castration-resistant prostate …
Biomarkers for the management of castration-resistant prostate cancer: we are not there yet
DP Petrylak, ED Crawford - Targeted Oncology, 2017 - Springer
In recent years, there has been a marked increase in the number of approved therapies that
increase survival of patients with castration-resistant prostate cancer. Current treatment …
increase survival of patients with castration-resistant prostate cancer. Current treatment …
The CCL 17‐CCR 4 axis between endometrial stromal cells and macrophages contributes to the high levels of IL‐6 in ectopic milieu
WJ Zhou, XX Hou, XQ Wang… - American Journal of …, 2017 - Wiley Online Library
Endometriosis is a chronic inflammatory disease characterized by the elevation of
proinflammatory cytokines, such as IL‐6, in the peritoneal fluid. However, the precise …
proinflammatory cytokines, such as IL‐6, in the peritoneal fluid. However, the precise …
STAT3 in Prostate Cancer
N Don-Doncow - 2017 - portal.research.lu.se
STAT3 in Prostate Cancer Don-Doncow, Nicholas Page 1 STAT3 in Prostate Cancer Don-Doncow,
Nicholas 2017 Document Version: Publisher's PDF, also known as Version of record Link to …
Nicholas 2017 Document Version: Publisher's PDF, also known as Version of record Link to …